Literature DB >> 8655925

Virilization associated with choriocarcinoma.

R Rajatanavin1, S Chuahirun, L Chailurkit, S Srisupundit, S Tungtrakul.   

Abstract

We demonstrate here two autopsy-proven cases of virilization associated with choriocarcinoma. The first patient was a 27-year-old woman with a 7-year history of metastatic choriocarcinoma who presented with left hemiparesis and virilization. Serum testosterone concentration was 18 nmol/l, free testosterone 471 pmol/l, dehydroepiandrosterone sulphate (DHEA-sulphate) 1.7 mumol/l, sex hormone binding globulin 12.3 nmol/l, estradiol (E2) 1,843 pmol/l, and hCG 1.6 x 10(5) IU/l. The second patient was a 21-year-old virilized woman with metastatic choriocarcinoma who presented in semicomatose state. Limited endocrine investigation revealed serum testosterone 27 nmol/l and hCG 2.7 x 10(5) IU/l. Both patients died despite chemotherapy and radiation therapy. Autopsy findings revealed choriocarcinoma with brain and multiple organ metastasis in both. Pathology of the ovaries of both patients demonstrated hyperplasia of luteinized theca cells and lutein cells. We postulate that an association of virilization and choriocarcinoma resulted from long-standing stimulation of ovary by hCG causing theca cell hyperplasia with subsequent hypertestosteronemia and virilization.

Entities:  

Mesh:

Year:  1995        PMID: 8655925     DOI: 10.1007/BF03349784

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  12 in total

1.  Discordant results in human chorionic gonadotropin assays.

Authors:  L A Cole; A Kardana
Journal:  Clin Chem       Date:  1992-02       Impact factor: 8.327

Review 2.  Specificity spillover at the hormone receptor--exploring its role in human disease.

Authors:  J E Fradkin; R C Eastman; M A Lesniak; J Roth
Journal:  N Engl J Med       Date:  1989-03-09       Impact factor: 91.245

3.  Trophoblastic hyperthyroidism: clinical and biochemical features of five cases.

Authors:  R Rajatanavin; L O Chailurkit; S Srisupandit; S Tungtrakul; S Bunyaratvej
Journal:  Am J Med       Date:  1988-08       Impact factor: 4.965

4.  Plasma testosterone levels in trophoblastic disease and the effects of oophorectomy and chemotherapy.

Authors:  N A Samaan; J P Smith; F N Rutledge; J M Barcellona
Journal:  J Clin Endocrinol Metab       Date:  1972-03       Impact factor: 5.958

5.  Hydatidiform mole--a cause of clinical hyperthyroidism. Report of two cases with evidence that the molar tissue secreted a thyroid stimulator.

Authors:  J M Hershman; H P Higgins
Journal:  N Engl J Med       Date:  1971-03-18       Impact factor: 91.245

6.  Plasma testosterone in molar pregnancy: Correlation with gestational age, uterine size, theca-lutein cyst and serum HCG.

Authors:  P C Chew; S S Ratnam; H H Goh
Journal:  Br J Obstet Gynaecol       Date:  1978-08

7.  Clinical and laboratory investigation of a virilized woman with placental-site trophoblastic tumor.

Authors:  S B Nagelberg; S W Rosen
Journal:  Obstet Gynecol       Date:  1985-04       Impact factor: 7.661

8.  Thyrotropic activity of basic isoelectric forms of human chorionic gonadotropin extracted from hydatidiform mole tissues.

Authors:  M Yoshimura; A E Pekary; X P Pang; L Berg; T M Goodwin; J M Hershman
Journal:  J Clin Endocrinol Metab       Date:  1994-04       Impact factor: 5.958

9.  Testosterone production with hydatidiform moles--in vitro and in vivo studies.

Authors:  P C Chew; H H Goh; S S Ratnam
Journal:  Br J Obstet Gynaecol       Date:  1979-01

10.  Effect of peptide nicking in the human chorionic gonadotropin beta-subunit on stimulation of recombinant human thyroid-stimulating hormone receptors.

Authors:  M Yoshimura; A E Pekary; X P Pang; L Berg; L A Cole; A Kardana; J M Hershman
Journal:  Eur J Endocrinol       Date:  1994-01       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.